HOME >> BIOLOGY >> NEWS
Hopkins scientists show enzyme is key to hallmark of Alzheimer's

Scientists at Johns Hopkins have demonstrated that a specific enzyme in the brain is essential for nerve cells to form a hallmark of Alzheimer's disease (AD) - the so-called amyloid plaques that collect and surround brain cells. While aging brains of apparently healthy people contain scattered amyloid plaques, the brains of AD patients are littered with them.

Last year, five research groups cloned the gene for the enzyme, called beta-secretase, but the Hopkins scientists say they are the first to show the enzyme is responsible for forming the molecules that comprise plaque within the brain's nerve cells. Beta amyloid - the plaque molecule - forms inside nerve cells, then is shuttled outside where it collects into plaques.

Beta-secretase is a topic of intense research interest for pharmaceutical and academic centers worldwide because it's one of two enzymes associated with plaque formation. Many scientists believe plaques are the probable trigger of AD's destruction in the brain. "Knowing this enzyme is the major player in forming plaques offers a way to tell if the structures truly are important in Alzheimer's. And if that's the case, the enzyme also offers a clear target for therapy," says research team member Philip Wong, Ph.D.

The research is scheduled for presentation at this year's meetings of the Society for Neuroscience in New Orleans.

In the Hopkins study, scientists knocked out the genes for beta-secretase in mice. They then cultured nerve cells from the animals' brains and, using antibodies targeted to beta-secretase, confirmed the enzyme wasn't present. As expected, the nerve cells lacking the enzyme failed to form beta amyloid, the plaque protein.

"The mice without beta-secretase genes are born apparently normal and seem to suffer no untoward effects, but we're watching the mice as they age," says Huaibin Cai, Ph.D., another of the researchers. "So far, at four months, the mice appear fine."

"We're really enc
'"/>

Contact: Marjorie Centofanti
mcentofanti@jhmi.edu
410-955-8725
Johns Hopkins Medical Institutions
5-Nov-2000


Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Hopkins is first US institution to obtain powerful genotyping system
9. Dr. Robot tested at Hopkins
10. From Hopkins: Children may outgrow peanut allergies
11. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is ... has more than 20-years of telecommunications experience and over ten years in executive leadership. ... was acquired by CallTower in early 2018. , In this new role, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, ... that recognizes women of excellence in the field of intellectual property, and named ... Dwyer Women in IP Award aims to encourage and support women in their ...
(Date:8/26/2018)... ... August 25, 2018 , ... ... impact of a biofield energy treated nutraceutical to reduce inflammation and autoimmune disorders ... function and blood, as well as inflammation. The following data was reported:, ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... August 28, 2018 , ... ... spinal implants, announced today the successful completion of a $5.5 million funding round ... Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. , “Our investment in ...
(Date:8/29/2018)... ... August 28, 2018 , ... CEO and ... a safety study performed on an allogeneic (donor derived) stem cell product for ... (NAVRMA) conference in September. He is also the organizer of Breakout Session ...
(Date:8/26/2018)... LINDA, Calif. (PRWEB) , ... August 23, 2018 ... ... virtual events for tech innovators, engineers, and scientists from around the world, will ... Immunology 2018 will cover an array of industries and disciplines, encompassing various research ...
(Date:8/23/2018)... STATION, N.J. (PRWEB) , ... August 23, 2018 , ... ... University by Visikol Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers ... years later. , Visikol’s path from an idea to a successful biotech company ...
Breaking Biology Technology:
Cached News: